IP Library Granted Patent US 7,211,420
Granted Patent B1
US 7,211,420 · App. 09/856,339 · Granted May 1, 2007

Process for oxidizing terpenes

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,211,420
App. No.
09/856,339
Granted
May 1, 2007
Kind
B1
Abstract

A process for oxidizing a substrate which is an acyclic or cyclic terpene, or a cycloalkene; or a substituted derivative thereof, which process comprises oxidizing said compound with a mutant haem-containing enzyme, the mutant comprising the substitution of an amino acid in the active site by an amino acid with a less polar side-chain. The enzyme is typically P450 cam or P450 BM-3 . Cells and libraries of cells in which the process can be carried out or which can be used to select advantageous mutant enzymes are also provided.

Claims (6)

1. A process for oxidizing a substrate wherein said substrate is a limonene or pinene or a cyclic sesquiterpene, wherein said limonene, pinene or cyclic sesquiterpene is optionally substituted by an alkyl of 1 to 6 carbons or an alkenyl of 1 to 6 carbons, and wherein the process comprises: oxidizing said substrate with a mutant haem-containing P450 enzyme, wherein said mutant enzyme is a mutant of a P450 BM-3 comprising the amino acid sequence of SEQ ID NO:24 and said mutant enzyme only has mutations at one or more of the following amino acid positions: 42, 51, 181, 263, 264 and 354 and wherein said mutant enzyme has a higher oxidation activity towards the substrate which is being oxidized than the enzyme having the sequence SEQ ID NO:24, and wherein at least one of said mutations is a substitution of an amino acid by another amino acid.

2. The process according to claim 1 in which the enzyme is one in which amino acid 51 of P450 BM-3 has been changed to another amino acid.

3. The process according to claim 1 in which the P450 BM-3 mutant comprises the mutation Y51F.

4. The process according to claim 1 in which the substrate is selected from the group consisting of limonene, pinene, and substituted derivatives thereof.

5. The process according to claim 1 in which the substrate is a cyclic sesquiterpene, or a substituted derivative thereof.

6. The process according to claim 5 in which the substrate is selected from the group consisting of aromadendrene, carophyllene, longifolene, valencene, isobazzanene, silphinene, ishwarane, isopatchchoul-3-ene, isosesquicarene, and substituted derivatives thereof.

Assignments (1)
CHANGE OF NAME Recorded Aug 2, 2016
From: ISIS INNOVATION LIMITED
To: OXFORD UNIVERSITY INNOVATION LIMITED
Reel/Frame 039550/0045 →